NEW YORK, June 13, 2017 /PRNewswire/ --
Today's research on DailyStockTracker.com is focused on the
Medical Appliances and Equipment space, which includes companies
that are engage in the manufacture of medical instruments such as
dental and surgical appliances. Lined up for review this morning
are: Neovasc Inc. (NASDAQ: NVCN), NuVasive Inc. (NASDAQ: NUVA),
Amedica Corp. (NASDAQ: AMDA), and Accuray Inc. (NASDAQ: ARAY).
Learn more about these stocks by signing up for their free reports
on DailyStockTracker.com at:
http://dailystocktracker.com/register/
Neovasc
On Monday, shares in Richmond,
Canada headquartered Neovasc Inc.
recorded a trading volume of 62,085 shares. The stock ended the
session 2.00% lower at $1.47. The
Company's shares have gained 4.26% in the last one month and 5.00%
over the previous three months. The stock is trading 20.05% above
its 200-day moving average. Moreover, shares of Neovasc, which
develops, manufactures, and markets cardiovascular products
worldwide, have a Relative Strength Index (RSI) of 44.50. The free
research report on NVCN is available at:
http://dailystocktracker.com/registration/?symbol=NVCN
NuVasive
San Diego, California
headquartered NuVasive Inc.'s stock closed the day 1.74% lower at
$77.75. A total volume of 973,752
shares was traded, which was above their three months average
volume of 615,120 shares. The Company's shares have advanced 9.12%
in the past month, 4.29% in the previous three months, and 15.42%
since the start of this year. The stock is trading 5.18% and 11.97%
above its 50-day and 200-day moving averages, respectively.
Additionally, shares of NuVasive, which develops and markets
minimally-disruptive surgical products and procedurally-integrated
solutions for spine surgery, have an RSI of 61.11.
On June 05th, 2017,
NuVasive announced the PRECICE® system and PRECICE UNYTE™ platform
from NuVasive Specialized Orthopedics are featured in the
June 2017 supplement of the Journal
of Orthopaedic Trauma, which demonstrates a lower complication
rate, greater patient comfort, and faster healing in comparison to
traditional treatments.
On June 06th, 2017,
research firm RBC Capital Markets reiterated its 'Outperform'
rating on the Company's stock with an increase of the target price
from $76 a share to $85 a share. The complimentary report on NUVA can
be downloaded at:
http://dailystocktracker.com/registration/?symbol=NUVA
Amedica
Shares in Salt Lake City, Utah
headquartered Amedica Corp. recorded a trading volume of 1.14
million shares, which was higher than their three months average
volume of 560,550 shares. The stock ended yesterday's trading
session 1.47% lower at $0.34. The
Company's shares are trading below their 50-day moving average by
7.51%. Furthermore, shares of Amedica, which develops,
manufactures, and sells a range of medical devices based on its
silicon nitride ceramic technology platform in the US, Europe, and South
America, have an RSI of 51.49.
On June 08th, 2017,
Amedica announced its preliminary earnings report for Q4 and fiscal
year ended December 31st,
2016. For Q4 2016, the Company reported preliminary revenue of
$3.6 million and GAAP net loss of
$0.16 per share. For the full year,
revenue was $15.2 million and GAAP
net loss was $1.19 per share.
Additionally, cash and cash equivalents were $6.9 million at December
31st, 2016. Visit us today and download our
complete research report on AMDA for free at:
http://dailystocktracker.com/registration/?symbol=AMDA
Accuray
Sunnyvale, California
headquartered Accuray Inc.'s stock finished Monday's session 5.75%
lower at $4.10 with a total trading
volume of 813,799 shares. The Company's shares are trading below
their 50-day moving average by 6.56%. Shares of the company, which
designs, develops, and sells radiosurgery and radiation therapy
systems for the treatment of tumors in the body, have an RSI of
42.91.
On May 24th, 2017,
Accuray announced that it has appointed, Stan Gee, who has been with the Company for over
eight years, to the newly created Vice President of Revenue
Management position reporting to Kevin
Waters, CFO. Mr. Gee will be responsible for driving the
global revenue forecast and overseeing the order to revenue
conversion process for the Company. Get free access to your
technical report on ARAY at:
http://dailystocktracker.com/registration/?symbol=ARAY
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. DST has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
DST has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email contact@dailystocktracker.com.
Rohit Tuli, a CFA® charterholder
(the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the
content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written
and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by DST. DST is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. DST, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, DST, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither DST nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA